VRTX Vertex Pharmaceuticals
- 400.980
- +0.820+0.20%
Vertex Pharmaceuticals News
Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Vertex Pharmaceuticals | SC TO-T: Third party tender offer statement
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I
Vertex Pharmaceuticals | PX14A6G: Notice of exempt solicitation
Vertex Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Vertex Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Vertex Pharmaceuticals | 8-K: Current report
Vertex Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Vertex Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital World Investors(10.0%)
Vertex Pharmaceuticals | ARS: Annual Report to Security Holders
Vertex Pharmaceuticals | DEFA14A: Others
Vertex Pharmaceuticals | DEF 14A: Definitive information statements
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ambrose Kristen
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kewalramani Reshma
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Atkinson Edward Morrow III
Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arbuckle Stuart A
Analysis
Price Target
No Data
